Perinatal OUD Continuity & Retention
Drug overdose is now a leading cause of pregnancy-associated death, with rates rising from 6.9 to 12.2 per 100,000 mothers between 2018 and 2021. More than 60% of these deaths occur outside healthcare settings, peaking at 7–12 months postpartum.
- 64.1% of women maintained MOUD for the full 12 months postpartum in Massachusetts cohort
- Only 34% continuation if MOUD initiated in final month before delivery vs 80% for full pregnancy
- 12-month Medicaid extension increases MOUD months by 8.55%
- MOUD is the only factor consistently associated with reduced postpartum overdose
Epidemiology
Opioid use disorder during pregnancy has escalated dramatically:
- Prevalence increased from ~1.5 to 6.5 per 1,000 delivery hospitalizations (1999-2014), with continued rise
- In Florida (2017), drug-related deaths were the leading cause of maternal mortality, accounting for 1 in 4 deaths
- 75% of drug-related maternal deaths occurred postpartum
Critical Window: The postpartum period (especially 7-12 months) represents peak overdose risk. Treatment discontinuation and loss of physiologic tolerance converge to create lethal vulnerability.
Predictors of MOUD Retention
Handoff Failure Points
| Transition | Failure Mechanism | Consequence |
|---|---|---|
| Prenatal → L&D | MOUD dose not communicated; pain plan absent | Undertreated pain → AMA discharge; precipitated withdrawal |
| L&D → Postpartum | Inconsistent MOUD continuation orders | Missed doses; early discharge |
| Hospital → Home (0-14 days) | No warm handoff to outpatient MOUD prescriber | Highest vulnerability; loss to follow-up |
| 6 Weeks → 6 Months | Medicaid ended at 60 days; no OUD-specific follow-up | Insurance loss; emerging postpartum depression |
| 6-12 Months → Primary Care | Pediatric visits continue but maternal OUD follow-up lapses | Peak overdose window without safety net |
Care Models Comparison
| Model | Key Features | Retention Evidence |
|---|---|---|
| Co-located OB–Addiction Clinic | Single site: OB + addiction medicine + mental health + social work | 69% at 6 months; fewer missed postpartum appointments |
| Low-Threshold Bridge Buprenorphine | Same-day/next-day buprenorphine start; no service prerequisites | "Medication First" doubles treatment entry |
| OTP Linkage | Daily dosing; structure and accountability | Methadone ≥60 mg improves retention |
| Tele-MOUD | Video/phone buprenorphine initiation and maintenance | 48% vs 44% 90-day retention; 3.8% vs 9.7% 6-mo discontinuation |
| Peer Recovery Support | Certified peer specialists embedded in clinical/community settings | Nearly doubles MOUD acceptance at warm handoff |
Policy Environment Effects
Punitive policies (criminalization, civil commitment): Associated with 43% higher odds of no planned MOUD; 45% increase in opioid overdoses among pregnant women; significantly greater NAS rates.
Supportive policies (treatment funding, Medicaid extension): Implementation increased MOUD receipt by 11%; decreased opioid overdoses by 45%.
Key Policy Interventions
- Medicaid postpartum extension to 12 months: Increases MOUD months by 8.55%; increases likelihood of continuing MOUD beyond 60 days by 5.12%
- Telehealth flexibilities: Now permanent for buprenorphine initiation via phone/video
- Removal of X-waiver requirement (2023): Any DEA-licensed prescriber may now prescribe buprenorphine
Standardized Warm Handoff Bundle
Pre-Discharge (Antepartum/L&D)
- Confirm MOUD dose and prescriber documented in discharge orders
- Complete Plan of Safe Care collaboratively with family
- Provide prenatal NOWS education to family
- Consult anesthesia for pain management plan
- Verify outpatient MOUD appointment scheduled within 7 days
At Discharge
- Naloxone first-aid kit provided to every postpartum person (76% acceptance rate demonstrated)
- Medication reconciliation including MOUD, psychotropics, contraception
- Warm handoff = direct introduction between inpatient team and outpatient MOUD prescriber
- Peer recovery specialist contact offered; contacts within 48 hours if accepted
- Written resource packet with MOUD prescriber contact, crisis line, community resources
Post-Discharge Checkpoints
- 48-hour peer/care coordinator phone check-in
- 7–14 day outpatient visit (MOUD refill + wound check + mental health screen)
- 6-week comprehensive postpartum visit (MOUD, contraception, PHQ-9, Edinburgh, PCL-5)
- Monthly touchpoints through 6 months; quarterly through 12 months
- At 12 months: structured transition to primary care with addiction medicine warm handoff
QI-Ready Metrics Dashboard
Process Measures
| Measure | Target |
|---|---|
| MOUD initiation within 7 days of OUD identification | ≥80% |
| Postpartum follow-up within 7–14 days | ≥75% |
| Naloxone provision/education at discharge | ≥90% |
| Warm-handoff completion rate | ≥85% |
Outcome Measures
| Measure | Target |
|---|---|
| MOUD continuation at 6 weeks postpartum | ≥75% |
| MOUD continuation at 6 months postpartum | ≥55% |
| MOUD continuation at 12 months postpartum | ≥45% |
| Fatal and nonfatal overdose events | Trending downward |
ASAM Criteria Application
Use ASAM dimensions at intake and each transition to ensure level-of-care alignment:
- D1 (Withdrawal): Prevent withdrawal in pregnancy; stabilize with MOUD
- D2 (Medical): Address pregnancy complications, Hep C, HIV
- D3 (Psychiatric): Screen for depression, PTSD, anxiety
- D4 (Readiness): Pregnancy often increases motivation
- D5 (Relapse):>/strong> Assess triggers; polysubstance use in 65%
- D6 (Environment): Housing, IPV, childcare, recovery supports